Respiratory Protection for Healthy Adults Exposed to Wood Smoke
(MASKON Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand how wood smoke affects heart and lung health in healthy adults when exposed to different components of the smoke. Participants will wear a special respirator that filters out various elements of the smoke during two separate sessions. The trial is suitable for healthy individuals aged 18-35 who can comfortably exercise on a bike for about an hour. As an unphased trial, it offers participants the opportunity to contribute to important research on environmental health impacts.
Do I need to stop taking my current medications for the trial?
Yes, you will need to stop taking certain medications for the trial. You cannot take any prescription or over-the-counter medications (except birth control) for one week before the bronchoscopy. Additionally, you must stop taking dietary supplements, vitamins, Omega-3 supplements, prebiotics, probiotics, and antihistamines for the duration of the study.
What prior data suggests that this protocol is safe for healthy adults?
Research has shown that N95 masks are generally safe and effective for protecting people from harmful substances in smoke, such as during wildfires. N95 masks filter out most harmful particles and are designed for safety in various settings, not just workplaces.
In contrast, surgical masks offer less protection against smoke. They mainly filter larger particles and are less effective for the tiny particles or gases found in smoke.
Both types of masks have been widely used and are considered safe for general use, with no major safety concerns about wearing them during this study.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how different masks—specifically, NIOSH certified N95 respiratory masks and surgical masks—can protect healthy adults from wood smoke exposure. While typical treatments for smoke exposure focus on managing symptoms after exposure, this study looks at prevention through personal protective equipment. The unique aspect here is evaluating the effectiveness of these masks in a controlled environment where participants are exposed to a specific concentration of wood smoke while exercising. This could provide valuable insights into the best ways to protect individuals who are regularly exposed to wood smoke, enhancing safety measures beyond traditional symptom management.
What evidence suggests that this trial's treatments could be effective for respiratory protection against wood smoke?
In this trial, participants will wear different types of masks while exposed to wood smoke. Research has shown that N95 masks, one of the masks tested, can block at least 95% of tiny particles, including those as small as 0.3 micrometers. This makes them effective at filtering most small particles in wood smoke. Some studies suggest these masks also help reduce exposure to certain gases in wood smoke.
Surgical masks, another type tested in this trial, are moderately effective, blocking 25–81% of larger particles. They do not filter very small particles and gases as well as N95 masks. Both types offer some protection, but N95 masks generally perform better at keeping harmful particles and gases out.678910Who Is on the Research Team?
James Samet, PhD
Principal Investigator
Environmental Protection Agency (EPA)
Are You a Good Fit for This Trial?
The MASKON trial is for young, healthy adults aged 18-35 with normal lung and heart function. Participants must have a BMI between 19 and 30, be able to do mild exercise on a bike, and be fully vaccinated against COVID-19.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Exposure Session 1
Participants undergo the first exposure to woodsmoke with virtually all particulate matter and volatile organic compounds removed, while exercising intermittently.
Follow-up Session 1
Participants are monitored for health effects approximately 24 hours after the first exposure, including bronchoscopy and nasal epithelial lining fluid collection.
Exposure Session 2
Participants undergo the second exposure to woodsmoke with only particulate matter removed, allowing volatile organic compounds to pass, while exercising intermittently.
Follow-up Session 2
Participants are monitored for health effects approximately 24 hours after the second exposure, including bronchoscopy and nasal epithelial lining fluid collection.
Final Follow-up
Participants are monitored for safety and effectiveness after the completion of both exposure sessions.
What Are the Treatments Tested in This Trial?
Interventions
- NIOSH certified N95 personal face covering (mask)
- Surgical Mask
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of North Carolina, Chapel Hill
Lead Sponsor
Environmental Protection Agency (EPA)
Collaborator